CoreRx, Inc. Completes Acquisition of Societal CDMO, Inc.
CLEARWATER, Fla., April 08, 2024 (GLOBE NEWSWIRE) — CoreRx, Inc. (“CoreRx”) today announced that it has completed its acquisition of […]
Magnite to Announce First Quarter 2024 Financial Results on May 8, 2024
NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) — Magnite (Nasdaq: MGNI), the world’s largest independent sell-side advertising company, will announce […]
WEYCO Group, Inc. First Quarter 2024 Earnings Conference Call
MILWAUKEE, WI, April 08, 2024 (GLOBE NEWSWIRE) — WEYCO Group, Inc. (NASDAQ: WEYS), a global marketer of footwear, plans to […]
Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 that Supports Ongoing First-line RAS-mutated mCRC Clinical Study
RAS-mutated mCRC – In RAS-mutated mCRC, novel preclinical finding demonstrates onvansertib inhibits the tumor’s ability to adapt to hypoxia resulting in […]
NN, Inc. Announces Another Strong Quarter of New Business Awards at $17.2 million in Q1 2024
CHARLOTTE, N.C., April 08, 2024 (GLOBE NEWSWIRE) — NN, Inc. (NASDAQ: NNBR), a global diversified industrial company that engineers and […]
HeartCore Reports Full Year 2023 Results and Provides Strategic Priorities for 2024
NEW YORK and TOKYO, April 08, 2024 (GLOBE NEWSWIRE) — HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or “the Company”), a […]
Mondelēz International to Report Q1 2024 Financial Results on April 30, 2024
CHICAGO, April 08, 2024 (GLOBE NEWSWIRE) — Mondelēz International, Inc. (Nasdaq: MDLZ) will release its first quarter 2024 financial results […]
Sprout Social to Announce First Quarter 2024 Financial Results on May 2, 2024
CHICAGO, April 08, 2024 (GLOBE NEWSWIRE) — Sprout Social, Inc. (“Sprout Social”, the “Company”) (Nasdaq: SPT), an industry-leading provider of […]
Tenable Recognized as a Cyber AI Leader on the First-Ever CRN AI 100 List
COLUMBIA, Md., April 08, 2024 (GLOBE NEWSWIRE) — Tenable®, the Exposure Management company, today announced it has been recognized by […]
Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting
PHILADELPHIA, April 08, 2024 (GLOBE NEWSWIRE) — Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell […]
